• Home
  • Walden University
  • Decision Making in Healthcare DDHA 8600
  • Decision Making in Healthcare Ethics and Regulations

Decision Making in Healthcare Ethics and Regulations

Week 9 Diss DDHA 8600 Post an explanation of what steps you, as a current or future healthcare administration leader, might take to address the issues with IRB as presented in the scenario. The current leadership need to defer IRB oversight to another IRB until corrective action has been taken to ensure the IRB is functioning in an ethical manner. The use of external IRB is very common practice in many institutions. When relying on an external IRB, whether it is for a single research project or a portion of the organization's research portfolio, the external IRB will meet Federal regulations for the conduct of research and IRB review. Studies on human are imperative for medical progress and have expanded our understanding and capability to treat serious diseases and entities. However, research with humans needs to consider the ethical dimensions of the reasons for running an experiment and the proper procedural steps to ensure that the results reflect good science. Protecting human participants in research is top priority and has been given great consideration in the ethical conduct of research because the exact risks and benefits of research are uncertain (Wolf, 2005) Researchers must effectively organize their resources to efficiently assess the many issues that arise during a clinical study. There are numerous ethical standards that govern research with human participants in the United States which are codified in the CFR. While regulations may evolve over time, the primary IRB responsibility of protecting the rights and welfare of humans participating in research studies will continue(Kim, 2012). Unfortunately, instances where clinical investigators fail to acquire proper IRB oversight have occurred. In these cases, the investigator is often dismayed to find out an IRB cannot retrospectively review their study and, because of such, they cannot publish results in a peer- reviewed journal or use the data in a regulatory submission. Questions that arise often include(Parker, 2016): - Does an IRB need to oversee my research study? - Will my project require continual IRB oversight? - What level of IRB review does my investigation require? - Do I need to let the IRB know when my project is done? References Kim, W. (2012). Institutional review board (IRB) and ethical issues in clinical research. Korean Journal Of Anesthesiology, 62(1), 3. https://doi.org/10.4097/kjae.2012.62.1.3 Parker, G. (2016). A Framework for Navigating Institutional Review Board (IRB) Oversight in the Complicated Zone of Research. Cureus, 8(10). https://doi.org/10.7759/cureus.844 Wolf, L. (2005). Human Subjects Issues and IRB Review in Practice-Based Research. The Annals Of Family Medicine, 3(suppl_1), S30-S37. https://doi.org/10.1370/afm.302 Hi XXX, An organization is considered engaged in human research when its employees or agents, for the purposes of the research project obtain 1) data about the subjects of the research through intervention or interaction with them; 2) identifiable private information about the subjects of the research; 3) informed consent of human subjects for the research; OR 4) a direct federal award to conduct human subject research, even when all activities involving human subjects are carried out by subcontractors fii.e. employees or